Autonomic Technologies Investors

36 investors on Angel Roster list Autonomic Technologies in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the Netherlands and France.

Investors are matched on the company name in their portfolio, so companies that share the name Autonomic Technologies can appear together.

Investors listed
36
With verified email
39%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 36 Autonomic Technologies investors

The most complete profiles first. Showing 36 of 36.

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Olivier LitzkaVerified

    Venture Capital, Private Equity Firm, Investor · Germany

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, Noxxon Pharma and 83 more

    Verified email available

  • paul klingensteinVerified

    Venture Capital · United States

    Series BSeries AHealth CareWearablesHospitalsWellness

    Portfolio: Alibris, goBalto, Kit Check, Eledon Pharmaceuticals and 32 more

    Verified email available

  • Adam WhiteheadVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Ben WessnerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Brian EnglanderVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Doug FisherVerified

    Venture Capital · United States

    Health CareHospitalsE-commerceAccounting

    Portfolio: Crowdpac, Welcome Software, Cuyana, Joyus and 52 more

    Verified email available

  • Dylan HarmonVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Karen WilsonVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsE-commerceAccounting

    Portfolio: Crowdpac, Welcome Software, Cuyana, Joyus and 51 more

    Verified email available

  • Scott LiVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Stephen HolmesVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsE-commerceAccounting

    Portfolio: Crowdpac, Welcome Software, Cuyana, Joyus and 51 more

    Verified email available

  • Todd HolmesVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Alexandre Foulon

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsDeepTech

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Arnaud Faure

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Mayeul Caron

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Pierre

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Asiya Giniatullina

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Bonnie van Wilgenburg

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carlo Incerti

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • David Robin

    Venture Capital, Private Equity Firm · France

    Health CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Justin Waney

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Luke Duster

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Nate Hukill

    Venture Capital, Private Equity Firm · Puerto Rico

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Pierre Morisseau

    Venture Capital, Private Equity Firm · France

    Health CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Sami Hawwa

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Sander van Deventer

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Vincent van Houten

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Zain Shekhani

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Autonomic Technologies investors are on Angel Roster?

Angel Roster lists 36 Autonomic Technologies investors. 14 of them (39%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (30), Private Equity Firms (26) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Autonomic Technologies investors invest in?

Among those that list a stage, the most common are Seed (7), Series B (6) and Series A (1).

Where are Autonomic Technologies investors based?

Most are based in the United States (14), the Netherlands (12) and France (6).

Which companies have Autonomic Technologies investors backed?

The most-backed portfolio companies among them are SANIFIT (21), Allecra Therapeutics (21), AM Pharma (21), Gotham Therapeutics (14) and CircuLite (14).

How do I contact Autonomic Technologies investors?

Create a free Angel Roster account to search and filter all 36, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.